S&P 500
(-0.07%) 5 465.31 points
Dow Jones
(0.08%) 39 143 points
Nasdaq
(0.16%) 17 746 points
Oil
(0.06%) $80.88
Gas
(-5.04%) $2.62
Gold
(-0.80%) $2 312.20
Silver
(-0.06%) $28.85
Platinum
(3.28%) $1 018.80
USD/EUR
(0.33%) $0.936
USD/NOK
(0.75%) $10.68
USD/GBP
(0.50%) $0.792
USD/RUB
(-0.27%) $87.25

Sanntidsoppdatering for Sigilon Therapeutics, [SGTX]

Børs: NASDAQ Sektor: Healthcare Industri: Biotechnology
Sist oppdatert10 aug 2023 @ 22:00

-2.56% $ 22.47

Live Chart Being Loaded With Signals

Commentary (10 aug 2023 @ 22:00):
Profile picture for Sigilon Therapeutics, Inc.

Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A...

Stats
Dagens volum 81 878
Gjennomsnittsvolum 120 683
Markedsverdi 56.22M
EPS $-3.00 ( Q2 | 2023-08-07 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.515
(Sector) 42.63
(Industry) 24.32
ATR14 $1.161 (5.17%)
AADI -6.47%
ABCL 2.01%
ABCM 0.04%
ABEO -2.99%
ABIO -1.68%
ABOS 4.44%
ABSI 5.10%
ABUS -0.66%
ABVX -2.03%
ACAD -0.06%
ACER -17.95%
ACET -9.25%
ACGN 1.29%
ACHL -1.63%
ACHV 3.02%
ACIU -2.00%
ACLX 0.39%
ACRV -4.71%
ACST -4.89%
ACXP 3.69%
ADAG 6.12%
ADAP -2.96%
ADGI 0.87%
ADIL 0.88%
ADMA -1.95%
ADPT 0.59%
ADTX -2.78%
ADVM 0.43%
ADXN -1.60%
AEON -2.80%
AEZS -2.49%
AFMD -1.92%
AGEN -3.06%
AGIO -2.04%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 4.52%
AKRO -2.89%
AKTX -2.38%
AKUS 0.00%
ALBO 0.00%
ALDX -2.08%
ALEC -0.80%
ALGS 1.32%
ALKS 1.45%
ALLK -11.44%
ALLO -4.17%
ALLR -3.85%
ALNA 3.16%
ALNY 2.92%
ALPN 0.02%
ALPX 0.00%
ALRN -2.24%
ALT -12.90%
ALVR -0.61%
ALXN 0.00%
ALXO -13.17%
ALZN 4.02%
AMRN -2.21%
AMTI -3.13%
ANAB 1.38%
ANEB 6.06%
ANGN 0.00%
ANIX -3.64%
ANL -0.14%
ANNX 2.40%
ANPC -3.15%
APGE 0.07%
APGN 8.48%
APGNW 30.65%
APLM -4.60%
APLS 1.05%
APLT -0.79%
APM 1.26%
APOP 0.38%
APRE 0.84%
APTO 4.82%
APTX 3.17%
APVO 0.93%
ARAV -13.39%
ARCT -5.60%
ARDS -12.13%
ARDX 1.25%
ARGX -0.37%
ARNA 0.00%
ARPO -0.90%
ARQT -2.66%
ARTL -2.50%
ARTLW 0.00%
ARVN 6.45%
ARWR -1.79%
ASLN -3.27%
ASMB -4.87%
ASND -2.05%
ATAI -3.70%
ATHA 7.31%
ATHE 0.56%
ATHX -33.50%
ATNF 0.99%
ATOS 5.34%
ATRA -3.48%
ATXI 2.70%
ATXS -0.52%
AUPH -0.99%
AURA 5.14%
AUTL -3.02%
AVBP -3.89%
AVEO 0.00%
AVIR -2.33%
AVRO -1.41%
AVTE 0.34%
AVTX -3.74%
AVXL -4.97%
AXLA 0.00%
AXSM -1.35%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 2.22%
BCAB -2.61%
BCDA -3.15%
BCDAW -41.77%
BCEL 0.00%
BCLI 4.21%
BCRX 1.40%
BCTX 8.16%
BCTXW 13.02%
BCYC 1.15%
BDRX -3.80%
BDTX 0.00%
BEAM 2.56%
BFRA -2.91%
BGNE -2.07%
BIOR -5.27%
BIVI 2.90%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -3.39%
BLTE -1.03%
BLU 0.03%
BLUE -1.84%
BMEA -13.05%
BMRN 0.16%
BNOX 6.15%
BNTC -1.69%
BNTX -1.60%
BOLD -8.47%
BOLT -0.09%
BPMC -1.14%
BPTH -1.90%
BPTS -13.47%
BRNS -0.37%
BRTX -6.10%
BTAI 16.92%
BTTX 20.00%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 2.95%
CABA 0.83%
CADL 0.35%
CALA 0.00%
CALC -3.74%
CALT -1.59%
CAPR -1.50%
CARA -3.27%
CARM 7.42%
CASI -1.65%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 0.55%
CCCC -2.34%
CCXI 0.00%
CDAK 0.00%
CDIO -4.99%
CDIOW 24.00%
CDMO -1.62%
CDMOP 0.04%
CDT -0.81%
CDTTW -39.60%
CDTX -6.53%
CDXC 7.38%
CDXS 8.97%
CELC -3.06%
CELU -1.83%
CELUW 11.80%
CERC -1.68%
CERE -1.59%
CERO -7.67%
CEROW -10.18%
CFRX -27.95%
CGEM -0.06%
CGEN -3.87%
CGON -1.59%
CGTX -4.35%
CHMA -6.00%
CHRS 4.13%
CINC 0.00%
CING -2.56%
CINGW 34.95%
CKPT -1.79%
CLBS -16.75%
CLDX -1.10%
CLGN 0.70%
CLLS -3.63%
CLNN 1.36%
CLNNW 0.00%
CLRB 7.06%
CLSD -2.40%
CLSN -0.68%
CLVS 0.00%
CMMB -3.89%
CMND 5.65%
CMPI 0.00%
CMPX -0.95%
CMRA 0.00%
CMRAW 33.33%
CMRX -4.43%
CNCE 0.00%
CNSP -35.80%
CNST 0.00%
CNTA -0.11%
CNTB -0.75%
CNTX -4.78%
COCP -2.00%
COEPW 32.45%
COGT -2.52%
CORT 2.24%
COYA -0.81%
CPRX -1.95%
CRBP -1.25%
CRBU -6.55%
CRDF 1.55%
CRGX 0.27%
CRIS -3.19%
CRNX -6.31%
CRSP -0.32%
CRTX 2.63%
CRVO -3.25%
CRVS 0.56%
CSBR 0.11%
CTCX -1.59%
CTIC 0.06%
CTMX -3.31%
CTNM 2.01%
CTXR 0.24%
CUE -1.04%
CVAC -9.18%
CVKD -2.34%
CWBR 2.80%
CYAD -12.96%
CYCC 8.49%
CYCCP 5.28%
CYCN 7.81%
CYT -2.27%
CYTK -2.82%
CYTO 0.90%
DARE 3.55%
DAWN -1.04%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 30.09%
DNLI -1.72%
DNTH -4.82%
DOMH 1.59%
DRMA -2.57%
DRMAW -1.25%
DRNA 0.00%
DRTS 1.85%
DRTSW 0.00%
DRUG 1.43%
DSGN -3.17%
DTIL -0.24%
DYAI 9.68%
EARS -1.77%
EDIT -2.92%
EDSA 4.09%
EFTR 3.51%
EFTRW -53.85%
EIGR -9.21%
ELAB -3.01%
ELDN 8.86%
ELEV -3.33%
ELOX 10.77%
ELTX -5.15%
ELVN -1.77%
ELYM 4.60%
ENGN -0.25%
ENGNW 0.00%
ENLV 0.00%
ENOB 1.79%
ENSC 6.53%
ENTA 0.16%
ENTO -4.97%
ENTX -0.53%
ENVB 8.30%
EPIX -0.73%
EPRX -1.92%
EPZM 0.00%
EQ 0.32%
EQRX -2.09%
EQRXW 0.00%
ERAS 0.00%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 16.64%
ETNB -3.82%
ETON 3.35%
ETTX 0.00%
EVAX -0.71%
EVGN 4.76%
EVLO 0.00%
EWTX -1.44%
EXAI -0.38%
EXEL 0.38%
EYEG -0.69%
EYEN 1.11%
EYPT 1.39%
FATE -11.42%
FBIO 0.90%
FBIOP 0.87%
FBLG -8.20%
FBRX -0.02%
FDMT -4.82%
FENC -2.74%
FGEN -9.83%
FHTX 7.82%
FIXX 0.77%
FMTX 0.00%
FNCH 0.00%
FOLD -1.52%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE 0.80%
FULC 1.84%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -0.45%
GANX -3.70%
GBIO -2.12%
GBT 0.01%
GDTC 0.50%
GERN -3.77%
GHRS -3.72%
GLMD -4.09%
GLPG -1.52%
GLSI 3.97%
GLTO -3.31%
GLUE -3.43%
GLYC -11.80%
GMAB -0.25%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -2.60%
GNLX -4.42%
GNPX -3.43%
GNTA 3.94%
GOSS -11.50%
GOVX -1.81%
GOVXW 10.89%
GPCR -6.60%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 0.48%
GRTX -1.66%
GTHX -0.91%
GUTS 3.00%
GXGXW 41.67%
GYRE -4.44%
HALO -1.74%
HARP 0.09%
HCWB -6.13%
HEPA -3.14%
HGEN -84.62%
HILS 5.66%
HLVX -1.91%
HOOK 0.48%
HOTH -1.62%
HOWL -0.43%
HRMY 4.57%
HRTX 8.69%
HSTO 0.00%
HUMA 1.01%
HUMAW -6.26%
IBRX -5.30%
ICCC -4.42%
ICPT 0.21%
ICU 19.78%
ICUCW 20.20%
ICVX -0.91%
IDRA -23.04%
IDYA -3.02%
IFRX -2.47%
IGMS -1.10%
IKNA -0.30%
IKT -6.03%
IMAB 0.00%
IMCR -3.22%
IMGN 0.02%
IMGO 0.00%
IMMP 3.99%
IMMX -5.65%
IMNM 3.38%
IMNN 0.91%
IMPL -27.27%
IMRA 15.96%
IMRN -0.40%
IMRX -3.50%
IMTX -1.25%
IMTXW 6.00%
IMUX 1.85%
IMV 0.00%
IMVT -3.41%
INAB -1.68%
INBX -1.99%
INCY -2.16%
INDP 8.49%
INFI -52.38%
INKT 2.10%
INM 0.04%
INMB 4.90%
INO 2.74%
INSM -1.21%
INTS -1.96%
INVA 0.15%
INZY 1.83%
IOBT -10.24%
IONS 1.08%
IOVA -2.66%
IPA 3.00%
IPHA 3.05%
IPSC -2.34%
IRON -2.70%
ISEE 0.38%
ITOS 0.82%
ITRM 2.33%
IVA 6.96%
IVVD 0.41%
JAGX 1.31%
JANX -4.53%
JAZZ -0.99%
JNCE 0.00%
JSPR -2.86%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -2.45%
KALV -4.07%
KDNY 0.22%
KMPH -0.34%
KNSA -1.98%
KNTE -0.38%
KOD -7.91%
KPRX -4.08%
KPTI -7.80%
KRBP -10.00%
KRON 0.62%
KROS -0.55%
KRRO -0.36%
KRTX 0.03%
KRYS 0.03%
KTRA 7.25%
KTTA -0.65%
KTTAW 0.92%
KURA 0.00%
KYMR -2.76%
KYTX -2.97%
KZIA 0.35%
KZR -0.14%
LABP 0.57%
LBPH -0.54%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.01%
LENZ -2.60%
LEXX -1.56%
LEXXW -14.63%
LGND -1.28%
LGNDV 0.00%
LGVN -8.51%
LIAN -8.28%
LIFE 2.70%
LIPO -5.10%
LIXT -9.76%
LIXTW 46.21%
LJPC -0.32%
LMNL 0.12%
LOGC 1.48%
LPCN -3.68%
LPTX -2.45%
LQDA 0.24%
LRMR 0.36%
LSTA -1.68%
LTRN 6.06%
LUMO 1.79%
LVTX -2.58%
LXEO -8.83%
LXRX -1.77%
LYEL -35.54%
LYRA 1.94%
MACK 0.10%
MBIO -11.05%
MBRX -2.03%
MCRB 3.04%
MDGL -2.79%
MDNA -13.16%
MDWD 2.81%
MDXG -2.28%
MEIP 0.00%
MESO -1.48%
MGNX -5.24%
MGTA -7.74%
MGTX -0.95%
MGX -0.80%
MIRM 0.00%
MIRO 0.59%
MIST 3.84%
MITO 0.00%
MLEC -7.68%
MLECW 2.31%
MLND -5.36%
MLTX 0.38%
MLYS -6.08%
MNKD -0.96%
MNMD 3.82%
MNOV 2.11%
MNPR -8.63%
MOLN 2.46%
MOR 0.45%
MORF -3.16%
MREO -2.57%
MRKR -0.42%
MRNA -8.64%
MRNS -6.99%
MRSN -2.63%
MRTX -0.17%
MRUS -0.75%
MRVI -1.02%
MTCR -1.29%
MTEM 6.93%
MTP -18.50%
MURA -4.02%
MYMD 1.08%
NAMS 0.48%
NAMSW -0.21%
NAUT 1.11%
NBRV 0.71%
NBSE -1.56%
NBTX 12.09%
NCNA 1.81%
NERV -1.58%
NEXI -0.74%
NGM -1.28%
NGNE 3.70%
NKGN 10.84%
NKGNW 8.00%
NKTR 3.74%
NKTX -4.24%
NLSP 3.24%
NLSPW 26.67%
NMRA -1.37%
NMTR -42.97%
NOVN -24.84%
NRBO 17.37%
NRIX -0.63%
NRSN -4.82%
NRSNW 0.00%
NRXP -8.18%
NRXPW 18.33%
NRXS -1.20%
NTBL 2.63%
NTEC -12.45%
NTHI 0.00%
NTLA -5.33%
NTRBW -31.07%
NUVL -1.70%
NVAX -7.64%
NVCT -7.75%
NVIV -34.28%
NXTC -4.11%
NYMX -0.05%
OABI 2.87%
OABIW -10.06%
OBIO -1.15%
OBSV 0.00%
OCEA -1.76%
OCGN 10.07%
OCS -1.00%
OCUL 0.69%
OCUP 0.65%
ODT -4.27%
OKYO 2.15%
OLMA -5.20%
OMER -3.08%
OMGA 1.67%
ONCO 6.08%
ONCR -3.08%
ONCS 31.87%
ONCT -2.35%
ONCY 3.45%
ONTX -0.47%
ONVO 0.29%
OPNT 0.00%
OPT 2.06%
ORGS 1.19%
ORIC -1.04%
ORMP 18.30%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.39%
OVID 0.01%
OYST 0.00%
PALI -0.22%
PASG 2.63%
PBLA -7.50%
PBM -2.46%
PBYI 3.04%
PCSA -1.93%
PCVX 0.54%
PDSB -6.17%
PEPG 1.37%
PGEN -5.80%
PHAR 2.19%
PHAS 0.00%
PHAT -0.48%
PHIO -3.58%
PHIOW 36.47%
PHVS -5.83%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.92%
PLUR 7.39%
PMN -5.55%
PMVP -1.79%
PNT 0.16%
PPBT -6.43%
PRAX 6.70%
PRDS 0.93%
PRLD -2.64%
PROG -3.47%
PROK 0.22%
PRQR 1.21%
PRTA -2.65%
PRTC 0.41%
PRTG 3.67%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -14.04%
PSTX -2.33%
PTCT -0.60%
PTE -0.82%
PTGX -0.92%
PTIXW -48.41%
PULM 1.53%
PXMD 4.76%
PYPD 1.71%
PYXS 4.41%
QLGN -5.70%
QNCX 5.70%
QNRX -0.49%
QSI -33.86%
QSIAW -3.13%
QTTB -0.14%
QURE -0.34%
RAIN -1.63%
RANI 4.81%
RAPT -1.30%
RARE 1.89%
RCKT -9.04%
REGN -0.51%
RENB -2.45%
REPL -1.59%
RETA 0.02%
REUN -0.89%
REVB -1.40%
REVBU 3.46%
REVBW 5.00%
RGLS -6.07%
RGNX -6.49%
RIGL -6.68%
RLAY -4.90%
RLMD -1.34%
RLYB -4.70%
RNA 1.09%
RNAC -4.45%
RNAZ 0.00%
RNXT 0.88%
ROIV -1.66%
ROIVW 4.56%
RPHM -1.24%
RPRX -0.67%
RPTX -0.44%
RUBY 2.70%
RVLP -32.05%
RVMD -0.70%
RVMDW -29.90%
RVNC -0.64%
RVPH -1.07%
RVPHW -5.28%
RXDX 0.09%
RXRX -5.49%
RYTM -5.52%
RYZB 0.02%
RZLT 2.56%
SABS -1.37%
SABSW -11.81%
SAGE 0.37%
SANA -3.41%
SAVA -1.50%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 0.32%
SCPH 10.86%
SCPS 0.00%
SEEL -3.17%
SEER 0.29%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -0.60%
SGMT -5.56%
SGTX -2.56%
SIOX 22.63%
SLDB -1.73%
SLGL 5.23%
SLN -7.27%
SLNO -0.44%
SLRX -0.40%
SLS -3.42%
SMMT -3.50%
SNDX 3.22%
SNGX -0.38%
SNPX -3.24%
SONN -0.01%
SPPI -0.49%
SPRB -1.59%
SPRC -4.25%
SPRO 0.75%
SRNE 0.00%
SRPT -1.39%
SRRA 0.00%
SRRK -1.61%
SRZN -2.45%
STAB 0.00%
STOK -6.81%
STRO -2.01%
STSA 0.00%
STTK 6.05%
SURF -0.93%
SVRA -1.71%
SWTX -0.11%
SYBX 1.29%
SYRS -1.99%
TALS -0.73%
TARA -7.62%
TARS -2.09%
TBPH 0.71%
TCBP 4.11%
TCDA 0.00%
TCON 0.00%
TCRR 0.00%
TCRT -1.74%
TCRX 4.19%
TECH -0.71%
TENX -0.32%
TERN -9.52%
TFFP -7.61%
TGTX -6.80%
THRX 0.12%
TIL -1.09%
TLC 0.00%
TLSA -7.74%
TNGX -3.56%
TNXP -5.98%
TNYA -5.08%
TPST 5.83%
TRDA -4.54%
TRVI 2.68%
TRVN 0.82%
TSHA -19.14%
TSVT -4.65%
TTNP -6.05%
TVTX 3.02%
TYRA -7.16%
UBX -2.55%
UNCY -4.23%
URGN 1.80%
UTHR 0.10%
VACC 11.36%
VALN -6.70%
VAXX 118.69%
VBIV 0.93%
VBLT -8.77%
VCEL 0.99%
VCNX 9.03%
VCYT -0.88%
VERA -6.03%
VERU 1.01%
VERV -2.39%
VIGL -1.88%
VINC 0.78%
VIR -0.49%
VIRI -4.53%
VIRX 3.98%
VKTX -1.67%
VLON -13.04%
VNDA -3.99%
VOR -6.05%
VRCA 0.14%
VRDN -3.84%
VRNA -1.73%
VRPX 1.02%
VRTX -0.04%
VSTM 3.40%
VTGN -1.66%
VTVT 0.39%
VTYX -2.72%
VXRT -2.13%
VYGR -0.77%
VYNE -4.29%
VYNT 7.78%
WINT -0.60%
WVE -8.18%
XBIO 1.03%
XBIT 7.29%
XCUR 3.77%
XENE -1.77%
XERS 4.52%
XFOR 5.73%
XLO 3.37%
XLRN 0.00%
XNCR 0.21%
XOMA -9.36%
XOMAO -0.45%
XOMAP -0.82%
XRTX -7.96%
YMAB -1.55%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -3.73%
ZNTL -1.79%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2023-08-11 Flagship Ventures Fund V General Partner Llc Sell 113 960 Common Stock
2023-08-11 Eli Lilly & Co Buy 1 718 493 Common Stock
2023-08-11 Cole Douglas G. Sell 683 Stock Option (Right to Buy)
2023-08-11 Cole Douglas G. Sell 683 Stock Option (Right to Buy)
2023-08-11 Oesterle Stephen N. Sell 683 Stock Option (Right to Buy)
INSIDER POWER
69.03
Last 96 transactions
Buy: 15 034 169 | Sell: 5 311 777

Volum Korrelasjon

Lang: 0.16 (neutral)
Kort: 0.00 (neutral)
Signal:(71.261) Neutral

Sigilon Therapeutics, Korrelasjon

10 Mest positive korrelasjoner
DICE0.802
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Sigilon Therapeutics, Korrelasjon - Valuta/Råvare

The country flag 0.46
( neutral )
The country flag -0.43
( neutral )
The country flag 0.87
( strong )
The country flag 0.40
( neutral )
The country flag -0.57
( weak negative )
The country flag -0.75
( moderate negative )

Sigilon Therapeutics, Økonomi

Annual 2022
Omsetning: $12.94M
Bruttogevinst: $12.94M (100.00 %)
EPS: $-1.340
FY 2022
Omsetning: $12.94M
Bruttogevinst: $12.94M (100.00 %)
EPS: $-1.340
FY 2021
Omsetning: $9.60M
Bruttogevinst: $0.00 (0.00 %)
EPS: $-2.43
FY 2020
Omsetning: $13.37M
Bruttogevinst: $13 374.00 (0.10 %)
EPS: $-7.55

Financial Reports:

No articles found.

Sigilon Therapeutics, Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Sigilon Therapeutics,

Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neurological manifestations of mucopolysaccharidosis type 1; SIG-007 to provide continuous and prolonged release of functional enzyme at levels sufficient to produce clinical benefits and alleviate progression of the downstream aspects of Fabry disease; and SIG-002 to replace islet cells for the treatment of type 1 diabetes. Sigilon Therapeutics, Inc. has a research collaboration and license agreement with Eli Lilly and Company for the development and commercialization of SLTx product candidates for the treatment of Type 1 Diabetes. The company was formerly known as Sigilon, Inc. and changed its name to Sigilon Therapeutics, Inc. in June 2017. Sigilon Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.

Total Execution Time: 2.2654929161072 seconds
Number of API calls: 3
Number of DB calls: 9